البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
TUROCTOCOG ALFA
NOVO NORDISK LTD, ISRAEL
B02BD02
POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
TUROCTOCOG ALFA 250 IU / 4 ML
I.V
Required
NOVO NORDISK A/S, DENMARK
COAGULATION FACTOR VIII
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).NovoEight can be used for all age groups.
2015-09-21
1 The content of this leaflet was approved by the Ministry of Health in September 2015 and updated according to the guidelines of the Ministry of Health in January 2019 1. NAME OF THE MEDICINAL PRODUCT NovoEight 250 IU powder and solvent for solution for injection NovoEight 500 IU powder and solvent for solution for injection NovoEight 1000 IU powder and solvent for solution for injection NovoEight 1500 IU powder and solvent for solution for injection NovoEight 2000 IU powder and solvent for solution for injection NovoEight 3000 IU powder and solvent for solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION NovoEight 250 IU powder and solvent for solution for injection. Each powder vial contains nominally 250 IU human coagulation factor VIII (rDNA), turoctocog alfa. After reconstitution NovoEight contains approximately 62.5 IU/ml of human coagulation factor VIII (rDNA), turoctocog alfa. NovoEight 500 IU powder and solvent for solution for injection. Each powder vial contains nominally 500 IU human coagulation factor VIII (rDNA), turoctocog alfa. After reconstitution NovoEight contains approximately 125 IU/ml of human coagulation factor VIII (rDNA), turoctocog alfa. NovoEight 1000 IU powder and solvent for solution for injection. Each powder vial contains nominally 1000 IU human coagulation factor VIII (rDNA), turoctocog alfa. After reconstitution NovoEight contains approximately 250 IU/ml of human coagulation factor VIII (rDNA), turoctocog alfa. NovoEight 1500 IU powder and solvent for solution for injection. Each powder vial contains nominally 1500 IU human coagulation factor VIII (rDNA), turoctocog alfa. After reconstitution NovoEight contains approximately 375 IU/ml of human coagulation factor VIII (rDNA), turoctocog alfa. NovoEight 2000 IU powder and solvent for solution for injection. Each powder vial contains nominally 2000 IU human coagulation factor VIII (rDNA), turoctocog alfa. After reconstitution NovoEight contains approximately 500 IU/ml of human coagulation factor VIII (rDNA), turoctocog اقرأ الوثيقة كاملة